Brainstorm Cell Therapeutics Inc (NAS:BCLI)
$ 0.62 0.053 (9.35%) Market Cap: 43.45 Mil Enterprise Value: 40.08 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Brainstorm Cell Therapeutics Inc (BCLI) Transcripts

  • 1